Stromal contribution to the colorectal cancer transcriptome

Nature Genetics

Volumn 47, Issue 4, 2015, Pages 312-319

  Isella, Claudio ^a,b   Terrasi, Andrea ^b   Bellomo, Sara Erika ^a,b   Petti, Consalvo ^a   Galatola, Giovanni ^a   Muratore, Andrea ^a   Mellano, Alfredo ^a   Senetta, Rebecca ^b   Cassenti, Adele ^b   Sonetto, Cristina ^c   Inghirami, Giorgio ^a   Trusolino, Livio ^a,b   Fekete, Zsolt ^c   De Ridder, Mark ^d   Cassoni, Paola ^b   Storme, Guy ^e   Bertotti, Andrea ^a,b   Medico, Enzo ^a,b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Institute of Oncology Prof Dr Ion Chiricuta Cluj Napoca   (Romania)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME; TUMOR MARKER;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM CANCER; STEM SERRATED MESENCHYMAL GENE; STROMA CELL; UPREGULATION; ANIMAL; COLORECTAL TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; MICE; MICROARRAY ANALYSIS; STROMAL CELLS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84925701525     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3224     Document Type: Article

References (57)

1. Walther, A. et al. Genetic prognostic and predictive markers in colorectal cancer. Nat. Rev. Cancer 9, 489-499 (2009)
2. Cunningham, D. et al. Colorectal cancer. Lancet 375, 1030-1047 (2010)
3. De Sousa, E. & Melo, F. et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat. Med. 19, 614-618 (2013)
4. Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619-625 (2013)
5. Marisa, L. et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 10, e1001453 (2013)
6. Sadanandam, A. et al. Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications. Cell Cycle 13, 353-357 (2014)
7. Pai, R.K. et al. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am. J. Surg. Pathol. 35, 1373-1380 (2011)
8. Farmer, P. et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat. Med. 15, 68-74 (2009)
9. Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013)
10. Bertotti, A. et al. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov. 1, 508-523 (2011)
11. Chou, J. et al. Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice. PLoS ONE 8, e79874 (2013)
12. Julien, S. et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin. Cancer Res. 18, 5314-5328 (2012)
13. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012)
14. Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5, e15543 (2010)
15. Lex, A. et al. StratomeX: visual analysis of large-scale heterogeneous genomics data for cancer subtype characterization. Comput. Graph. Forum 31, 1175-1184 (2012)
16. Mathew, S. et al. The gene for fibroblast activation protein (FAP), a putative cell surface-bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23. Genomics 25, 335-337 (1995)
17. Fearon, D.T. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance. Cancer Immunol. Res. 2, 187-193 (2014)
18. Laizé, V., Martel, P., Viegas, C.S., Price, P.A. & Cancela, M.L. Evolution of matrix and bone -carboxyglutamic acid proteins in vertebrates. J. Biol. Chem. 280, 26659-26668 (2005)
19. Peinado, H., Olmeda, D. & Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428 (2007)
20. Nishimura, G. et al. EF1 mediates TGF- signaling in vascular smooth muscle cell differentiation. Dev. Cell 11, 93-104 (2006)
21. Funahashi, J., Sekido, R., Murai, K., Kamachi, Y. & Kondoh, H. -crystallin enhancer binding protein EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development 119, 433-446 (1993)
22. Carter, S.L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413-421 (2012)
23. Calon, A. et al. Dependency of colorectal cancer on a TGF-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571-584 (2012)
24. Mootha, V.K. et al. PGC-1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003)
25. Uronis, J.M. et al. Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS ONE 7, e38422 (2012)
26. Huang, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009)
27. Martelli, M.L. et al. Exploiting orthologue diversity for systematic detection of gain-of-function phenotypes. BMC Genomics 9, 254 (2008)
28. Conway, T. et al. Xenome-a tool for classifying reads from xenograft samples. Bioinformatics 28, i172-i178 (2012)
29. Salazar, R. et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J. Clin. Oncol. 29, 17-24 (2011)
30. Popovici, V. et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J. Clin. Oncol. 30, 1288-1295 (2012)
31. De Sousa, E. & Melo, F. et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 9, 476-485 (2011)
32. Oh, S.C. et al. Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. Gut 61, 1291-1298 (2012)
33. Jorissen, R.N. et al. Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin. Cancer Res. 15, 7642-7651 (2009)
34. Smith, J.J. et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958-968 (2010)
35. Loboda, A. et al. EMT is the dominant program in human colon cancer. BMC Med. Genomics 4, 9 (2011)
36. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010)
37. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387 (2014)
38. Gutman, D.A. et al. Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data. J. Am. Med. Inform. Assoc. 20, 1091-1098 (2013)
39. Suárez, J. et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis. 10, 563-568 (2008)
40. Budinska, E. et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J. Pathol. 231, 63-76 (2013)
41. Yang, A.D. et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 12, 4147-4153 (2006)
42. Merlos-Suárez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511-524 (2011)
43. Medema, J.P. Cancer stem cells: the challenges ahead. Nat. Cell Biol. 15, 338-344 (2013)
44. Sautès-Fridman, C. et al. Tumor microenvironment is multifaceted. Cancer Metastasis Rev. 30, 13-25 (2011)
45. Micke, P. & Ostman, A. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin. Ther. Targets 9, 1217-1233 (2005)
46. Torres, S. et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin. Cancer Res. 19, 6006-6019 (2013)
47. Chargari, C., Clemenson, C., Martins, I., Perfettini, J.L. & Deutsch, E. Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resist. Updat. 16, 10-21 (2013)
48. Saigusa, S. et al. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int. J. Oncol. 38, 655-663 (2011)
49. Schneider, S. et al. Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharmacogenet. Genomics 16, 555-563 (2006)
50. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006)
51. Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567-6572 (2002)
52. Hoshida, Y., Brunet, J.P., Tamayo, P., Golub, T.R. & Mesirov, J.P. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2, e1195 (2007)
53. Hollingshead, M.G. et al. Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages-strategies for data mining in support of therapeutic studies. BMC Genomics 15, 393 (2014)
54. Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005)
55. Sandberg, R. & Larsson, O. Improved precision and accuracy for microarrays using updated probe set definitions. BMC Bioinformatics 8, 48 (2007)
56. Isella, C., Renzulli, T., Cora, D. & Medico, E. Mulcom: a multiple comparison statistical test for microarray data in Bioconductor. BMC Bioinformatics 12, 382 (2011)
57. Gentleman, R.C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).